What we are studying
The purpose of this study is to compare investigational topical treatment (Q301) 1.0 % and 1.4% to placebo and see what works better and is safe in people with atopic dermatitis (a skin condition that can cause skin to be red, itchy and inflamed). You will have a 2 in 3 chance in getting the investigational medication. Your study participation will last for up to 16 weeks with 7 visits to the study site.
Compensation will be discussed with the study team.